Vanguard disaggregates holdings; AtriCure (NASDAQ: ATRC) shows 0 shares
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
AtriCure Inc Schedule 13G/A Amendment No. 6: The Vanguard Group reports beneficial ownership of 0 shares of Common Stock, representing 0%. The filing notes an internal realignment on January 12, 2026 that disaggregated reporting by Vanguard subsidiaries. The amendment is signed by Ashley Grim on 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Amendment clarifies Vanguard's disaggregated reporting; no beneficial stake reported.
The filing explicitly states 0 shares beneficially owned and 0% of the class, reflecting the post‑realignment reporting structure described in SEC Release No. 34-39538.
Timing and cash‑flow treatment are not relevant here; subsequent filings by Vanguard subsidiaries may show any holdings separately.
FAQ
What does the January 12, 2026 realignment mean in the 13G/A?
It means certain Vanguard subsidiaries now report holdings separately, per SEC Release No. 34-39538. The filing states subsidiaries pursue the same strategies and Vanguard no longer is deemed to beneficially own those subsidiary holdings.
Who signed the Schedule 13G/A amendment for ATRC?
The filing is signed by Ashley Grim, Head of Global Fund Administration, on 03/26/2026. The signature certifies the disclosure about beneficial ownership and internal realignment.
Will separate Vanguard entities file their own disclosures for ATRC?
Yes, the amendment indicates subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538. Individual subsidiary filings may show holdings going forward.